Dihydromyricetin 50 g | 98%
Nature Science Technologies Ltd
Dihydromyricetin
Search Results
(±)14(15)-EpETE 25 µg | ≥90%
Cayman Chemical
(±)14(15)-EpETE
(±)14(15)-EpETE 1 mg | Purity Not Available
TargetMol
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator. However, the […]
More Information Supplier Page(±)15-HEDE 1 mg | Purity Not Available
TargetMol
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. There are no reports in the literature of biological activity associated with (±)15-HEDE.
More Information Supplier Page(±)15-HEDE
(±)15-Hede inquiry | Purity Not Available
Alfa Chemistry
(±)15-HEDE 250 µg | ≥98%
Cayman Chemical
(±)15-HEDE
(±)15-HEDE 100 µg | ≥98%
Cayman Chemical
(±)15-HEDE
(±)15-HEDE 50 µg | ≥98%
Cayman Chemical
(±)15-HEDE
(±)15-HEDE 25 µg | ≥98%
Cayman Chemical
(±)15-HEDE
(±)15-HEDE 25mg | ≥90%
Musechem
(±)15-HEPE 1 mg | Purity Not Available
TargetMol
(±)15-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 15(S)-HEPE and 15(R)-HEPE. Specific biological activity attributed to (±)15-HEPE has not been documented.
More Information Supplier Page(±)15-HEPE
